BMRNBiomarin Pharmaceutical Inc. - Registered Shares
BMRN
Biomarin Pharmaceutical Inc. - Registered Shares5,318
Mkt Cap
$11.59BVolume
2.41M52W High
$73.5152W Low
$50.76PE Ratio
22.61BMRN Fundamentals
Price
$58.95Prev Close
$60.35Open
$60.5250D MA
$55.22Beta
0.72Avg. Volume
2.93MEPS (Annual)
$2.21P/B
1.91Rev/Employee
$933,949.67BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA BioMarin to Present at the 44th Annual J.P. Morgan...
PR Newswire·1d ago
Veeva and BioMarin Form Long-Term Strategic Partnership
Veeva and BioMarin Form Long-Term Strategic Partnership Veeva and BioMarin Form Long-Term Strategic Partnership PR Newswire PLEASANTON, Calif., and SAN RAFAEL, Calif., Jan. 8, 2026 Partnership to...
PR Newswire·1d ago
19,329 Shares in BioMarin Pharmaceutical Inc. $BMRN Acquired by Financiere des Professionnels Fonds d investissement inc.
Financiere des Professionnels Fonds d investissement inc. bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 3rd quarter, according to the company in...
MarketBeat·6d ago
Blue Trust Inc. Sells 17,973 Shares of BioMarin Pharmaceutical Inc. $BMRN
Blue Trust Inc. decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 94.5% in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·7d ago
VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stock Position in BioMarin Pharmaceutical Inc. $BMRN
VIRGINIA RETIREMENT SYSTEMS ET Al cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 37.3% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·9d ago
Cwm LLC Has $8.90 Million Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN
Cwm LLC grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 86.9% in the third quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·11d ago
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Consensus Rating of "Moderate Buy" from Analysts
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has been given an average rating of "Moderate Buy" by the twenty-five research firms that are covering the company, MarketBeat.com...
MarketBeat·11d ago
Rice Hall James & Associates LLC Boosts Stock Position in BioMarin Pharmaceutical Inc. $BMRN
Rice Hall James & Associates LLC grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1,693.1% in the 3rd quarter, according to the company in its most recent...
MarketBeat·13d ago
BioMarin Pharmaceutical Inc. $BMRN Shares Acquired by Pacer Advisors Inc.
Pacer Advisors Inc. lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 10,580.1% during the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·14d ago
Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Amicus Therapeutics, Inc. (NasdaqGM: FOLD) to...
Business Wire·14d ago
<
1
2
...
>